Delusional Disorder clinical trials

Explore recruiting delusional disorder clinical trials.

Recruiting delusional disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Delusional Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Acute Effects of Partial GABA(A)-Receptor Modulation by GT-002 on Psychophysiological Measures: The TOTEMS Phase II Clinical Trial Targeting Cognitive Impairment Associated with Schizophrenia

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Delusional Disorder trials by city

Delusional Disorder in Toronto Delusional Disorder in Vancouver Delusional Disorder in Montreal Delusional Disorder in Calgary Delusional Disorder in Edmonton Delusional Disorder in Ottawa Delusional Disorder in Winnipeg Delusional Disorder in Quebec City Delusional Disorder in Hamilton Delusional Disorder in Kitchener Delusional Disorder in London Delusional Disorder in Halifax Delusional Disorder in New York Delusional Disorder in Los Angeles Delusional Disorder in Chicago Delusional Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease